Table 3 Platelet reactivity and clopidogrel resistance in patients with and without diabetes mellitus
From: Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel
All | DM | Non DM | |
|---|---|---|---|
n = 98 | n = 63 | n = 35 | |
Pre-Ramadan | |||
PRU median (IQR) | 199 (157–251) | 200 (157–253) | 196 (157–248) |
Clopidogrel resistance n (%) | |||
PRU > 235 | 36 (36.7) | 23 (36.5) | 13 (37.1) |
PRU > 208 | 48 (48.9) | 33 (52.3) | 15 (42.8) |
Ramadan | |||
PRU median (IQR) | 212 (169–257) | 227 (176–261)* | 200 (159–252) £ |
Clopidogrel resistance n (%) | |||
PRU > 235 | 39 (39.7) | 27 (42.8) | 12 (34.2) |
PRU > 208 | 54 (55.1) | 38 (60.3) | 16 (45.7) |
Post-R (n = 109) | |||
PRU median (IQR) | 210 (166–251) | 216 (176–247)* | 202 (153–254) |
Clopidogrel resistance n (%) | |||
PRU > 235 | 39 (39.7) | 23 (36.5) | 16 (45.7) |
PRU > 208 | 52 (53.0) | 35 (55.5) | 17 (48.5) |